Skip to main content
Black Friday Sale - Get 40% off Vantage
Published loading...Updated

Wells Fargo & Company Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

Summary by defenseworld.net
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its price target reduced by investment analysts at Wells Fargo & Company from $15.00 to $12.00 in a research report issued on Friday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective indicates a potential upside of 7.33% from the stock’s previous close. Other research analysts have also recently…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

watchlistnews.com broke the news in on Friday, November 7, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal